« fPET-FDG: A new dynamic PET imaging method. | Main | Image-Guided Drug Design (Highlight in C&E News) »

[11C]Martinostat patent officially licensed by Cambridge-based pharmaceutical company

Over the past few years we worked hard to identify an imaging agent for class-I histone deacetylases (HDAC).  We have succeeded in developing a PET imaging agent, [11C]Martinostat, that can be used for imaging HDAC in the brain and major peripheral organs.  We are happy to announce that we now have non-exclusively licensed this technology to a Cambridge-based pharmaceutical company. Keep an eye out for more news to come about the progression of [11C]Martinostat to human brain imaging in late summer.